摘要
为规范我国双相障碍诊疗的临床治疗决策,全面提升双相障碍患者规范化诊断与治疗水平,中华医学会精神医学分会发起制定《中国双相障碍防治指南》(2025年版)(以下简称指南)。本计划书概要介绍该指南制定的背景和目的、制定方法、工作组成员及分工、指南注册、利益冲突、临床问题收集与遴选、指南依据的循证证据、撰写与外审、发布和传播等。
To standardize clinical treatment decisions and improve the comprehensive diagnosis and treatment of bipolar disorder in China,the Psychiatric Branch of the Chinese Medical Association initiated the Guidelines for the Prevention and Treatment of Bipolar disorder in China(2025 edition).This protocol summary describes the background and purpose of the guideline,the formulation method,working group members,division of responsibilities,guideline registration,conflicts of interest,collection and selection of clinical issues,the evidence-based foundation of the guideline,writing and external review,as well as publishing,dissemination,and other aspects.
作者
方贻儒
洪武
刘铁榜
李凌江
王刚
李涛
陈俊
邱昌建
于欣
施慎逊
白渊翰
Fang Yiru;Hong Wu;Liu Tiebang;Li Lingjiang;Wang Gang;Li Tao;Chen Jun;Qiu Changjian;Yu Xin;Shi Shenxun;Bai Yuanhan(Rujin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai Mental Health Center,Shanghai Jiao Tong University School of Medicine,Shanghai 200030,China;Shenzhen Mental Health Center/Shenzhen Kangning Hospital,Shenzhen 518020,China;The Second Xiangya Hospital Affiliated to Central South University,Changsha 410011,China;Beijing Anding Hospital Affliated to Capital Medical University,Beijing 100088,China;Zhejiang University School of Medicine Affiliated Mental Health Center/Hangzhou Seventh People's Hospital,Hangzhou 310013,China;Mental Health Center at West China Hospital Affiliated to Sichuan University,Chengdu 610041,China;Peking University Sixth Hospital,Beijing 10008,China;Huashan Hospital Affiliated to Fudan University,Shanghai 200040,China)
出处
《中华精神科杂志》
CAS
CSCD
北大核心
2023年第6期413-417,共5页
Chinese Journal of Psychiatry
